Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 5
2006 5
2007 2
2009 3
2010 4
2011 1
2012 2
2013 2
2014 8
2015 6
2016 10
2017 7
2018 6
2019 2
2020 3
2021 2
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study.
Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Nakamura R, Tsunemi T, Ogawa T, Eguchi H, Daida K, Kurita N, Ueno SI, Fukae J, Sako W, Shiina K, Nakajima S, Oji Y, Wakamori R, Saiki S, Nishioka K, Okuzumi A, Taniguchi D, Takeshige-Amano H, Fuse A, Nakajima A, Kano M, Kamo H, Yamashita Y, Shindo A, Yanagisawa N, Hattori N. Hatano T, et al. Among authors: fukae j. Mov Disord Clin Pract. 2024 Apr;11(4):352-362. doi: 10.1002/mdc3.13972. Epub 2024 Jan 24. Mov Disord Clin Pract. 2024. PMID: 38264844 Free PMC article. Clinical Trial.
Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study.
Hatano T, Sengoku R, Nagayama H, Yanagisawa N, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, Matsukawa MK, Terashi H, Kimura K, Tashiro J, Hirano S, Murakami H, Joki H, Uchiyama T, Shimura H, Ogaki K, Fukae J, Tsuboi Y, Takahashi K, Yamamoto T, Kaida K, Ihara R, Kanemaru K, Kano O. Hatano T, et al. Among authors: fukae j. Neurol Ther. 2024 Apr;13(2):323-338. doi: 10.1007/s40120-023-00574-6. Epub 2024 Jan 16. Neurol Ther. 2024. PMID: 38227133 Free PMC article.
Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study.
Hatano T, Kano O, Sengoku R, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, Matsukawa MK, Terashi H, Kimura K, Tashiro J, Hirano S, Murakami H, Joki H, Uchiyama T, Shimura H, Ogaki K, Fukae J, Tsuboi Y, Takahashi K, Yamamoto T, Yanagisawa N, Nagayama H. Hatano T, et al. Among authors: fukae j. BMC Neurol. 2022 Mar 3;22(1):71. doi: 10.1186/s12883-022-02600-w. BMC Neurol. 2022. PMID: 35241003 Free PMC article.
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD).
Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Fukae J, Nakamura R, Kurita N, Tsunemi T, Oji Y, Saiki S, Nishioka K, Takeshige-Amano H, Taniguchi D, Ogawa T, Kamo H, Eguchi H, Fuse A, Nakajima A, Kano M, Nakajima S, Yanagisawa N, Hattori N. Hatano T, et al. Among authors: fukae j. BMJ Open. 2022 Feb 11;12(2):e054129. doi: 10.1136/bmjopen-2021-054129. BMJ Open. 2022. PMID: 35149566 Free PMC article. Clinical Trial.
71 results